CapsoVision, Inc
CVNasdaqCIK 1378325HealthcareFiscal year ends Dec 31
Reports and events: 30 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2811:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000045 |
| 2026-09-1816:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001378325-26-000043 |
| 2026-08-1817:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000039 |
| 2026-08-1316:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001378325-26-000036 |
| 2026-08-1316:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000035 |
| 2026-07-0216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001378325-26-000026 |
| 2026-06-1214:14 ET | 8-K | 5.07 Shareholder vote results | 0001378325-26-000023 |
| 2026-05-1416:35 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001378325-26-000021 |
| 2026-05-1416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000019 |
| 2026-04-2812:39 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001378325-26-000013 |
| 2026-04-1716:34 ET | S-1 | Registration statement | 0001628280-26-025785 |
| 2026-03-2616:44 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001378325-26-000010 |
| 2026-03-2616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-26-000008 |
| 2026-03-2008:04 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-26-000004 |
| 2026-03-1316:32 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001378325-26-000002 |
| 2025-12-2916:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000043 |
| 2025-11-1316:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001378325-25-000040 |
| 2025-11-1316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-25-000039 |
| 2025-11-1016:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000031 |
| 2025-11-0308:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001378325-25-000027 |
| 2025-09-2616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001378325-25-000022 |
| 2025-09-0317:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001378325-25-000018 |
| 2025-08-1417:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001378325-25-000010 |
| 2025-08-1416:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001378325-25-000008 |
| 2025-07-1816:49 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001378325-25-000002 |
| 2025-07-0317:03 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155527 |
| 2025-06-2718:24 ET | S-1/A | Registration statement, amended | 0001193125-25-149285 |
| 2025-06-1317:00 ET | S-1/A | Registration statement, amended | 0001193125-25-140836 |
| 2025-05-3017:11 ET | S-1/A | Registration statement, amended | 0001193125-25-132293 |
| 2025-05-0916:11 ET | S-1 | Registration statement | 0001193125-25-116894 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.